semaglutide
5 Shocking Prescription Weight Loss Side‑Effect Sins
Starting semaglutide typically triggers mild nausea in about 35% of patients, while tirzepatide leads to diarrhea in roughly 41%, both decreasing appetite within the first weeks. In clinical practice the two GLP-1 receptor agonists share a hunger-curbing effect, but their gastrointestinal footprints differ enough to shape patient counseling and monitoring